Jif recall could cost JM Smucker $125M, company warns

Jif recall could cost JM Smucker $125M, company warns

The JM Smucker Co. Warning Tuesday that the company stands to lose $125 million because of its nationwide Jif peanut butter recall last month.

In its latest earnings report, the company estimated that the “impact of manufacturing downtime, customer returns, and unsaleable inventory, as well as other recall related costs” could result in a $125 million loss for fiscal year 2023.

Ticker Security Last Change Change %
SJM THE JM SMUCKER CO. 127.44 -2.87 -2.20%

JIF ISSUES VOLUNTARY RECALL OF CERTAIN PEANUT BUTTER PRODUCTS DUE TO POTENTIAL SALMONELLA CONTAMINATION

The company also cautioned that the “ultimate impact from the Jif peanut butter recall could differ materially from these estimates.”

On May 20, JM Smucker voluntarily recalled select Jif peanut butter products that were sold across the US amid an outbreak of salmonella senftenberg infections.

JM Smucker Co. Jif brand peanut butter is displayed for sale at a Costco Wholesale Corp. store in Louisville, Kentucky, US, on Wednesday, May 29, 2019. (Luke Sharrett/Bloomberg via Getty Images / Getty Images)

According to federal health officials, the outbreak, which has left 16 people ill in 12 states, has been linked to certain Jif products produced at the JM Smucker facility in Lexington, Kentucky.

Two people have already been hospitalized, according to the Centers for Disease Control and Prevention (CDC).

So far Arkansas, Georgia, Illinois, Massachusetts, Missouri, Ohio, North Carolina, New York, South Carolina, Texas, Virginia and Washington have reported cases, according to the agency.

SALMONELLA OUTBREAK: SEVERAL COMPANIES PULL PRODUCTS MADE WITH JIF

However, the actual number of sick people is “likely much higher than the number reported, and the outbreak may not be limited to the states with known illnesses,” according to the CDC.

Since the recall, over a dozen other companies recalled products that contain JM Smucker brand peanut butter, according to the US Food and Drug Administration.

Leave a Comment

Your email address will not be published.